These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 32703017)
21. Modern treatment of retinoblastoma: A 2020 review. Ancona-Lezama D; Dalvin LA; Shields CL Indian J Ophthalmol; 2020 Nov; 68(11):2356-2365. PubMed ID: 33120616 [TBL] [Abstract][Full Text] [Related]
22. Secondary intra-arterial chemotherapy and/or intravitreal chemotherapy as salvage treatment for retinoblastoma. Mirzayev I; Gündüz AK; Yavuz K; Şekkeli MZ; Özalp Ateş FS; Ünal E; Taçyıldız N Eur J Ophthalmol; 2021 Sep; 31(5):2692-2698. PubMed ID: 32962409 [TBL] [Abstract][Full Text] [Related]
23. Retinoblastoma: a proposal for a multimodal treatment concept for intraocular retinoblastoma in Austria. Sovinz P; Urban C; Lackner H; Benesch M; Langmann G Wien Klin Wochenschr; 2006 Feb; 118(1-2):22-30. PubMed ID: 16489522 [TBL] [Abstract][Full Text] [Related]
24. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557 [TBL] [Abstract][Full Text] [Related]
25. [Retinoblastoma regression patterns and results following chemo reduction and adjuvant therapy]. Xue K; Qian J; Yue H; Yuan YF; Zhang R Zhonghua Yan Ke Za Zhi; 2012 Jul; 48(7):625-30. PubMed ID: 22943868 [TBL] [Abstract][Full Text] [Related]
27. Ocular preservation in patients with bilateral retinoblastoma before chemotherapy in situ era: A report from a Mexican Retinoblastoma Reference Hospital. Del Carmen Bernal-Díaz Z; Murillo-Maldonado MA; Pérez-Villanueva H; Reyes-López A; Ramírez-Ortiz MA Pediatr Blood Cancer; 2020 Oct; 67(10):e28625. PubMed ID: 32743978 [TBL] [Abstract][Full Text] [Related]
28. [Retinoblastoma: preliminary results of national treatment protocol at Casablanca university medical center]. El Kettani A; Aderdour S; Daghouj G; Knari S; Zaghloul K; Zafad S; Harif M; Benchekroun S J Fr Ophtalmol; 2014 Feb; 37(2):115-24. PubMed ID: 24507074 [TBL] [Abstract][Full Text] [Related]
29. Management outcome(s) in eyes with retinoblastoma previously inadequately treated with systemic chemotherapy alone without focal therapy. Yousef YA; Nazzal RM; Khalil MB; Deebajah R; Mehyar M; Hajja S; Mohammad M; Al Jabary R; Jaradat I; Sultan I; Al Nawaiseh I Oman J Ophthalmol; 2017; 10(2):70-75. PubMed ID: 28757689 [TBL] [Abstract][Full Text] [Related]
30. [Diode laser thermotherapy and chemothermotherapy in the treatment of retinoblastoma]. Lumbroso L; Doz F; Levy C; Dendale R; Vedrenne J; Bours D; Zucker JM; Asselain B; Desjardins L J Fr Ophtalmol; 2003 Feb; 26(2):154-9. PubMed ID: 12660589 [TBL] [Abstract][Full Text] [Related]
31. Retinoblastoma in Turkey--treatment and prognosis. Günalp I; Gündüz K; Arslan Y Jpn J Ophthalmol; 1996; 40(1):95-102. PubMed ID: 8739506 [TBL] [Abstract][Full Text] [Related]
33. Retinoblastoma associated with orbital pseudocellulitis and high-risk retinoblastoma: a study of 32 eyes. Kaliki S; Jakati S; Vempuluru VS; Mallu A; Mishra DK Int Ophthalmol; 2022 Jan; 42(1):19-26. PubMed ID: 34363179 [TBL] [Abstract][Full Text] [Related]
34. Outcomes of neonatal retinoblastoma in pre-chemotherapy and chemotherapy eras. Camp DA; Dalvin LA; Schwendeman R; Lim LS; Shields CL Indian J Ophthalmol; 2019 Dec; 67(12):1997-2004. PubMed ID: 31755437 [TBL] [Abstract][Full Text] [Related]
35. Risk factors for recurrent retinoblastoma after intravenous chemotherapy. Kaliki S; Vempuluru VS; Priya Y; Mohamed A Int Ophthalmol; 2021 Jun; 41(6):2033-2039. PubMed ID: 33611762 [TBL] [Abstract][Full Text] [Related]
36. A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma: Part II: Treatment Success and Globe Salvage. Tomar AS; Finger PT; Gallie B; Mallipatna A; Kivelä TT; Zhang C; Zhao J; Wilson MW; Brenna RC; Burges M; Kim J; Khetan V; Ganesan S; Yarovoy A; Yarovaya V; Kotova E; Yousef YA; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada G; Schaiquevich P; Fandino A; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Semenova E; Català J; Correa-Llano G; Carreras E; Ophthalmology; 2020 Dec; 127(12):1733-1746. PubMed ID: 32526306 [TBL] [Abstract][Full Text] [Related]
37. Clinical efficacy and prognostic factors of chemoreduction combined with topical treatment for advanced intraocular retinoblastoma. Liu Y; Zhang X; Liu F; Wang KL Asian Pac J Cancer Prev; 2014; 15(18):7805-9. PubMed ID: 25292067 [TBL] [Abstract][Full Text] [Related]
38. Clinical presentation and treatment outcome of retinoblastoma in children of South Western China. Gao J; Zeng J; Guo B; He W; Chen J; Lu F; Chen D Medicine (Baltimore); 2016 Oct; 95(42):e5204. PubMed ID: 27759657 [TBL] [Abstract][Full Text] [Related]
39. Globe conserving treatment of the only eye in bilateral retinoblastoma. Lee V; Hungerford JL; Bunce C; Ahmed F; Kingston JE; Plowman PN Br J Ophthalmol; 2003 Nov; 87(11):1374-80. PubMed ID: 14609838 [TBL] [Abstract][Full Text] [Related]
40. NEWLY DIAGNOSED ACTIVE RETINOBLASTOMA IN ADULTS. Kaliki S; Shields CL; Gupta A; Mishra DK; Das C; Say EA; Shields JA Retina; 2015 Dec; 35(12):2483-8. PubMed ID: 26035399 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]